D
Amylyx Pharmaceuticals, Inc. AMLX
$3.63 -$0.045-1.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Revenue -259.86% 140.66%
Total Other Revenue -- --
Total Revenue -259.86% 140.66%
Cost of Revenue -122.85% 89.34%
Gross Profit 121.87% -81.93%
SG&A Expenses -4.10% -17.64%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -47.44% 1.08%
Operating Income 46.27% 0.82%
Income Before Tax 47.48% -0.01%
Income Tax Expenses -- --
Earnings from Continuing Operations 48.36% -0.01%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 48.36% -0.01%
EBIT 46.27% 0.82%
EBITDA 46.32% 0.84%
EPS Basic 48.73% 0.09%
Normalized Basic EPS 34.41% 0.10%
EPS Diluted 48.84% 0.00%
Normalized Diluted EPS 34.41% 0.10%
Average Basic Shares Outstanding 0.74% 0.10%
Average Diluted Shares Outstanding 0.74% 0.10%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings